Abstract
Ferritin is a kind of glycoprotein synthesized by the liver. Being the main form of stored iron in the body, it plays an important role in the iron balance. When the iron level in the body increases, ferritin can intake and storage the iron avoiding the cytotoxicity caused by the high level of intracellular iron; when body needs more iron, ferritin can release iron at any time. Recent studies have found that tumor tissue can synthesize and secrete ferritin. Ferritin levels increase in liver cancer, lung cancer, pancreatic cancer, breast cancer, leukemia and other malignancies. In this paper, we reviewed the relationship between the changed ferritin and the malignancy disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wang W, Knovich MA, Coffman LG, et al. Serum ferritin: Past, present and future. Biochim Biophys Acta, 2010, 1800: 760–769.
Shpyleva SI, Tryndyak VP, Kovalchuk O, et al. Role of ferritin alterations in human breast cancer cells. Breast Cancer Res Treat, 2011, 126: 63–71.
Armand P, Kim HT, Cutler CS, et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood, 2007, 109: 4586–4588.
Zhou YY, Gu HN, Zheng TL. Clinical value of combination determination of serum CEA, CA199 and SF in gastric carcinoma. Int J Lab Med (Chinese), 2010, 31: 345–346.
Zhao J, Wang CY, Yang AJ, et al. Vasculogenic mimicry formation in hepatocellular carcinoma. Chinese-German J Clin Oncol, 2008, 7: 530–533.
Li QF. Value of serum ferritin combining with four other tumor markers in the diagnosis of lung cancer. J Hainan Med Univ (Chinese), 2012, 18: 171–174.
Huang WH, Chen RH, Yu JP, et al. Diagnostic value of tumor markers in breast cancer. Chin J Clin Med (Chinese), 2012, 19: 323–324.
Hunter HN, Fulton DB, Ganz T, et al. The solution structure of human hepcidin,a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem, 2002, 277: 376597–376603.
Kuvibidila S, Gauthier T, Warrier RP, et al. Increased levels of serum transferring receptor and serum transferring receptor/log ferritin ratios in men with prostate cancer and the implications for body-iron stores. J Lab Clin Med, 2004, 144: 176–182.
Richardson DR. Iron and neoplasia: Serum transferrin receptor and ferritin in prostate cancer. J Lab Clin Med, 2004, 144: 173–175.
Ali MA, Akhmedkhanov A, Zeleniuch-Jaquotte A, et al. Reliability of serum iron, ferritin, nitrite, and association with risk of renal cancer in women. Cancer Detect Prev, 2003, 27: 116–121.
Prutki M, Poljak-Blazi M, Jakopovic M, et al. Altered iron metabolism, transferring receptor 1 and ferritin in patients with colon cancer. Cancer Lett, 2006, 238: 188–196.
Carpagnano GE, Lacedonia D, Palladino GP, et al. Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes? Eur J Clin Invest, 2012, 42: 478–486.
Jézéquel P, Campion L, Spyratos F, et al. Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in nodenegative breast tumors: A multicentric 2004 national PHRC study. Int J Cancer, 2012, 131: 426–437.
Fang ZJ, Yu YF, Wang MD, et al. Clinical value of serum ferritin in acute and chronic Leukemia. Modern J Integ Traditi Chin Western Med (Chinese), 2012, 21: 3710–3711.
Sabbah EN, Kadouche J, Ellison D, et al. In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer. Nucl Med Biol, 2007, 34: 293–304.
Wang XP, Zhao CF, Qi HW, et al. Clinical significance of CSF ferritin in elderly patients with brain tumor. Chin J Gerontol (Chinese), 2011, 31: 227–228.